Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors
Derya Osmani̇ye, Berkant Kurban, Begüm Nurpelin Sağlık, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6640-6640
Open Access | Times Cited: 16

Showing 16 citing articles:

Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1823-1845
Open Access | Times Cited: 22
Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors
Mohammed Salah Ayoup, Ammar Ahmed, Hamida Abdel‐Hamid, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107102-107102
Closed Access | Times Cited: 7
Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity
Omar M. Al-Saad, Moustafa T. Gabr, Sarah S. Darwish, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116266-116266
Open Access | Times Cited: 6
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Hormoz Pourtaher, Alireza Hasaninejad, Aida Iraji
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
In vivo evaluation of the antinociceptive effects of novel methylsulfonyl group-containing compounds
Hazal Eken, Jale Akgöl, Berkant Kurban, et al.
Zeitschrift für Naturforschung C (2025)
Closed Access
New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
Liliana Păcureanu, Alina Bora, Luminita Crisan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9583-9583
Open Access | Times Cited: 9
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
Wiebke Ewert, Sebastian Günther, Francesca Miglioli, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 14
Design, Synthesis, and Biological Effect Studies of Novel Benzofuran–Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors
Derya Osmani̇ye, Begüm Nurpelin Sağlık, Serkan Levent, et al.
ACS Omega (2024) Vol. 9, Iss. 10, pp. 11388-11397
Open Access | Times Cited: 2
Indole-based thiosemicarbazones for neurodegenerative diseases as prolyl oligopeptidase inhibitors
Anam Rubbab Pasha, Ajmal Khan, Saeed Ullah, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138666-138666
Closed Access | Times Cited: 2
Inhibition of monoamine oxidases by heterocyclic derived conjugated dienones: synthesis, in vitro, and in silico investigations
Sunil Kumar, Bishnu Prasad Pandey, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders
Jeetendra Kumar Gupta, Kuldeep Singh, Alok Bhatt, et al.
3 Biotech (2024) Vol. 14, Iss. 11
Closed Access | Times Cited: 2
Synthesis, crystal structures and antimicrobial activities of 3-methyl and 3-bromo substituted benzo[b]thiophene based thiosemicarbazones
E. Öztürk, Elif Subaşı, E.S. Çakmakçı, et al.
Journal of Sulfur Chemistry (2023) Vol. 45, Iss. 1, pp. 101-119
Closed Access | Times Cited: 5
Computational exploration of acefylline derivatives as MAO-B inhibitors for Parkinson’s disease: insights from molecular docking, DFT, ADMET, and molecular dynamics approaches
Ali Irfan, Ameer Fawad Zahoor, Yassir Boulaamane, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Synthesis of novel thiosemicarbazone derivatives and investigation of their dual AChE and MAO‐B inhibitor effects
Ayşe Nur Uytun, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
Journal of Molecular Recognition (2022) Vol. 35, Iss. 12
Closed Access | Times Cited: 3
Design, Synthesis, in Vitro and Molecular Docking-Dynamics Studies of 5-(Diethylamino)-2-Formylphenyl Naphthalene-2-Sulfonate Based Thiosemicarbazones as Potent Anti-Alzheimer Agents
Silvia Schenone, Umar Farooq, Zahra Batool, et al.
(2024)
Closed Access
Yeni Pirol Türevlerinin Sentezi ve Karakterizasyonu, Monoamin Oksidaz İnhibisyon Özelliklerinin ve Moleküler Doking Çalışmalarının Araştırılması
Derya Osmani̇ye, Yusuf Özkay
Online Türk Sağlık Bilimleri Dergisi (2022) Vol. 7, Iss. 2, pp. 180-187
Open Access
Page 1

Scroll to top